October 15, 2025

EBSdart Tool Showed Strong Reliability in EBS

EBSdart introduces a standardized framework for epidermolysis bullosa simplex assessment.

Conexiant

October 14, 2025

Shingles Vaccine Effective in Immunocompromised Adults

Study of 3.5 million Medicare beneficiaries finds similar protection regardless of immune status.

Conexiant

October 14, 2025

Shingles Vaccine Effective in Immunocompromised Adults

Study of 3.5 million Medicare beneficiaries finds similar protection regardless of immune status.

Conexiant

October 09, 2025

Medical Tourism Surgeries Show Only 6% Complication Rate

Colombian center's outcomes match US registry data in analysis of 2,324 patients.

Conexiant

October 09, 2025

Medical Oddities: What Your Sleep Says About You

Five stories span sleep neuroscience, anti-aging dog training, a citrus misdiagnosis, green tea’s post-op benefits, and a gummy binge gone wrong.

Conexiant

October 06, 2025

More Tattoos, Lower Risk of Melanoma? New Study Investigates

People with more than one tattoo session may have a decreased risk of developing melanoma—with one key caveat, according to a study evaluating over 7,000 individuals.

The ASCO Post

October 06, 2025

Dupilumab Shows High Treatment Persistence in AD

Biologics target type 2 inflammation in atopic dermatitis, improving skin barrier and symptoms.

Conexiant

October 02, 2025

RP1 Oncolytic Therapy Provides New Hope for Patients Whose Melanoma Resists Conventional Immunotherapy

About half of all patients with advanced melanoma face a poor prognosis because their cancer doesn’t respond to immunotherapy — but results of a recent clinical trial show that an unusual treatment strategy could change that.

Roswell Park Comprehensive Cancer Center

October 02, 2025

Nicotinamide Use Reduces SCC in Veterans With Prior Skin Cancer

Veterans were prescribed nicotinamide twice daily following prior skin cancer.

Conexiant